Johan Verbraecken,Emanuele Amodio,Ozen K Basoglu,Riccardo Bellazzi,Matteo Bradicich,Marie Bruyneel,Refika Hamutcu Ersu,Francesco Fanfulla,Brigitte Fauroux,Ludger Grote,Carolina Lombardi,Walter T McNicholas,Carla Miltz,Yüksel Peker,Sofia Schiza,Monique Carolina Suarez,Renaud Tamisier,Hui-Leng Tan,Dries Testelmans,Thomy Tonia,Piet-Heijn van Mechelen,Bart Vrijsen,Maria R Bonsignore
{"title":"欧洲呼吸学会关于阻塞性睡眠呼吸暂停(e-Sleep)先进远程医疗的声明。","authors":"Johan Verbraecken,Emanuele Amodio,Ozen K Basoglu,Riccardo Bellazzi,Matteo Bradicich,Marie Bruyneel,Refika Hamutcu Ersu,Francesco Fanfulla,Brigitte Fauroux,Ludger Grote,Carolina Lombardi,Walter T McNicholas,Carla Miltz,Yüksel Peker,Sofia Schiza,Monique Carolina Suarez,Renaud Tamisier,Hui-Leng Tan,Dries Testelmans,Thomy Tonia,Piet-Heijn van Mechelen,Bart Vrijsen,Maria R Bonsignore","doi":"10.1183/13993003.00557-2025","DOIUrl":null,"url":null,"abstract":"Telemedicine (TM) as a means of remote patient-physician interaction is gaining popularity in nearly every field, and (respiratory) sleep medicine is no exception. Because obstructive sleep apnoea (OSA) is a chronic condition, and requires a continuous treatment and monitoring of therapy success, telematic communications could be useful to establish diagnostic and therapeutic strategies. This Statement summarises the evidence and efficacy of TM options in OSA. An interdisciplinary European Respiratory Society (ERS) Task Force (TF) evaluated the scientific literature based on a systematic search and two step screening process (title/abstract and full text). Although the TF does not make recommendations for clinical practice, it describes its current practice of TM applications in OSA. Literature shows that TM has been studied in different areas of OSA management, with potential benefits. TM also served as a major research tool to provide big data related to PAP therapy. TM results in similar or improved compliance when compared with traditional face-to-face encounters. TM-based targeted troubleshooting and support based on individual patient data, and a combination via smartphone apps or coaching websites, are feasible and effective. Expanding evidence suggests that TM is likely cost-effective. However, data do not consistently support staff time savings through TM-based solutions. The potential benefits of TM include improved access to health care, and increased adherence to (chronic illness) treatment plans. Benefits should be weighed against the overall costs of TM and risks related to suboptimal compliance.","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":"136 1","pages":""},"PeriodicalIF":21.0000,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"European Respiratory Society statement on advanced telemedicine for obstructive sleep apnoea (e-Sleep).\",\"authors\":\"Johan Verbraecken,Emanuele Amodio,Ozen K Basoglu,Riccardo Bellazzi,Matteo Bradicich,Marie Bruyneel,Refika Hamutcu Ersu,Francesco Fanfulla,Brigitte Fauroux,Ludger Grote,Carolina Lombardi,Walter T McNicholas,Carla Miltz,Yüksel Peker,Sofia Schiza,Monique Carolina Suarez,Renaud Tamisier,Hui-Leng Tan,Dries Testelmans,Thomy Tonia,Piet-Heijn van Mechelen,Bart Vrijsen,Maria R Bonsignore\",\"doi\":\"10.1183/13993003.00557-2025\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Telemedicine (TM) as a means of remote patient-physician interaction is gaining popularity in nearly every field, and (respiratory) sleep medicine is no exception. Because obstructive sleep apnoea (OSA) is a chronic condition, and requires a continuous treatment and monitoring of therapy success, telematic communications could be useful to establish diagnostic and therapeutic strategies. This Statement summarises the evidence and efficacy of TM options in OSA. An interdisciplinary European Respiratory Society (ERS) Task Force (TF) evaluated the scientific literature based on a systematic search and two step screening process (title/abstract and full text). Although the TF does not make recommendations for clinical practice, it describes its current practice of TM applications in OSA. Literature shows that TM has been studied in different areas of OSA management, with potential benefits. TM also served as a major research tool to provide big data related to PAP therapy. TM results in similar or improved compliance when compared with traditional face-to-face encounters. TM-based targeted troubleshooting and support based on individual patient data, and a combination via smartphone apps or coaching websites, are feasible and effective. Expanding evidence suggests that TM is likely cost-effective. However, data do not consistently support staff time savings through TM-based solutions. The potential benefits of TM include improved access to health care, and increased adherence to (chronic illness) treatment plans. Benefits should be weighed against the overall costs of TM and risks related to suboptimal compliance.\",\"PeriodicalId\":12265,\"journal\":{\"name\":\"European Respiratory Journal\",\"volume\":\"136 1\",\"pages\":\"\"},\"PeriodicalIF\":21.0000,\"publicationDate\":\"2025-09-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Respiratory Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1183/13993003.00557-2025\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Respiratory Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1183/13993003.00557-2025","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
European Respiratory Society statement on advanced telemedicine for obstructive sleep apnoea (e-Sleep).
Telemedicine (TM) as a means of remote patient-physician interaction is gaining popularity in nearly every field, and (respiratory) sleep medicine is no exception. Because obstructive sleep apnoea (OSA) is a chronic condition, and requires a continuous treatment and monitoring of therapy success, telematic communications could be useful to establish diagnostic and therapeutic strategies. This Statement summarises the evidence and efficacy of TM options in OSA. An interdisciplinary European Respiratory Society (ERS) Task Force (TF) evaluated the scientific literature based on a systematic search and two step screening process (title/abstract and full text). Although the TF does not make recommendations for clinical practice, it describes its current practice of TM applications in OSA. Literature shows that TM has been studied in different areas of OSA management, with potential benefits. TM also served as a major research tool to provide big data related to PAP therapy. TM results in similar or improved compliance when compared with traditional face-to-face encounters. TM-based targeted troubleshooting and support based on individual patient data, and a combination via smartphone apps or coaching websites, are feasible and effective. Expanding evidence suggests that TM is likely cost-effective. However, data do not consistently support staff time savings through TM-based solutions. The potential benefits of TM include improved access to health care, and increased adherence to (chronic illness) treatment plans. Benefits should be weighed against the overall costs of TM and risks related to suboptimal compliance.
期刊介绍:
The European Respiratory Journal (ERJ) is the flagship journal of the European Respiratory Society. It has a current impact factor of 24.9. The journal covers various aspects of adult and paediatric respiratory medicine, including cell biology, epidemiology, immunology, oncology, pathophysiology, imaging, occupational medicine, intensive care, sleep medicine, and thoracic surgery. In addition to original research material, the ERJ publishes editorial commentaries, reviews, short research letters, and correspondence to the editor. The articles are published continuously and collected into 12 monthly issues in two volumes per year.